HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bengt Widegren Selected Research

Therapeutic Uses

6/2012An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: potential therapeutic use in autoimmune diseases.
6/2007Neuroblastomas and medulloblastomas exhibit more Coxsackie adenovirus receptor expression than gliomas and other brain tumors.
8/2006Low-dose combretastatin A4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bengt Widegren Research Topics

Disease

11Neoplasms (Cancer)
01/2013 - 02/2002
10Glioma (Gliomas)
07/2010 - 02/2002
3Infections
01/2013 - 05/2006
3Glioblastoma (Glioblastoma Multiforme)
07/2010 - 10/2007
2Brain Neoplasms (Brain Tumor)
06/2007 - 05/2005
2Pancreatitis
07/2005 - 03/2005
1Hyperglycemia
01/2013
1Autoimmune Diseases (Autoimmune Disease)
06/2012
1Colonic Neoplasms (Colon Cancer)
11/2007
1Medulloblastoma
06/2007
1Neuroblastoma
06/2007
1Central Nervous System Neoplasms
06/2007
1Carcinoma (Carcinomatosis)
08/2006
1Lung Neoplasms (Lung Cancer)
05/2006
1Sepsis (Septicemia)
03/2005
1Lung Injury
03/2005
1Fibrosarcoma
03/2004

Drug/Important Bio-Agent (IBA)

3pyrimidin-2-one beta-ribofuranosideIBA
01/2013 - 11/2007
3Therapeutic UsesIBA
06/2012 - 08/2006
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2012 - 11/2007
2ProteomeIBA
07/2010 - 01/2009
2AntibodiesIBA
04/2010 - 05/2006
2AntigensIBA
04/2010 - 01/2009
2Proteins (Proteins, Gene)FDA Link
04/2010 - 01/2009
2Pharmaceutical PreparationsIBA
11/2007 - 08/2006
2Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA
06/2007 - 05/2006
2adenovirus receptorIBA
06/2007 - 05/2006
1AutoantigensIBA
01/2013
1Biomarkers (Surrogate Marker)IBA
07/2010
1Blood Proteins (Serum Proteins)IBA
07/2010
1Interferon-gamma (Interferon, gamma)IBA
04/2010
1Ku AutoantigenIBA
04/2010
1Immunotoxins (Immunotoxin)IBA
04/2010
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2009
1Messenger RNA (mRNA)IBA
01/2009
1Platelet-Derived Growth Factor alpha ReceptorIBA
04/2008
1Complementary DNA (cDNA)IBA
10/2007
1fosbretabulin (combretastatin A4)IBA
08/2006
1Nitric Oxide Synthase (NO Synthase)IBA
08/2006
1arginine methyl esterIBA
08/2006
1Telomerase (Telomerase Reverse Transcriptase)IBA
07/2006
1Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric
07/2005
1Histamine (Histamine Dihydrochloride)FDA Link
07/2005
1Mast Cell StabilizersIBA
07/2005
1Taurodeoxycholic AcidIBA
07/2005
1Oncostatin MIBA
05/2005
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2005
1DNA (Deoxyribonucleic Acid)IBA
09/2004
1Transforming Growth Factor beta (TGF-beta)IBA
03/2004
1ElementsIBA
03/2004
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2002
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2002

Therapy/Procedure

8Therapeutics
01/2013 - 08/2006
4Immunotherapy
07/2010 - 10/2007
1Nephrectomy
01/2013
1Radiotherapy
04/2010
1Intraperitoneal Injections
04/2010
1Aftercare (After-Treatment)
11/2007
1Drug Therapy (Chemotherapy)
08/2006
1Punctures
03/2005
1Ligation
03/2005